• Huawei Files Lawsuits Claiming Verizon Has Infringed On 12 Patents
    Verizon is allegedly using Huawei's technology without a license in such applications as its routers and switches and in enterprise services.
  • Macy's Shuttering 125 Stores As Part Of 3-Year Revitalization Plan
    "Our goal is to reclaim and revitalize what a department store should be," says Macy's chief executive Jeff Gennette.
  • FTC Wants To Stop Edgewell's Acquisition Of Harry's
    FTC charges "the loss of Harry's as an independent competitor would remove a critical disruptive rival that has driven down prices and spurred innovation."
  • As Consumers Shun Black Tea, Unilever Weighs Selling Lipton, PG Tips
    The "review was triggered by the sales slowdown of traditional black tea in developed markets as consumers shift towards herbal tea," reports Reuters.
  • IBM Keeps Its Head In The Cloud With Krishna Replacing Rometty As CEO
    Rometty "leaves on a recent high note, days after IBM reported its first revenue growth in six quarters, but... the turnaround she began remains a work in progress."
  • Wexner May Sell Stake in Victoria's Secret, Step Down As CEO Of L Brands
    "L Brands Inc. is in discussions with Sycamore Partners, a private-equity firm that has scooped up several troubled apparel brands," according to "WSJ."
  • Faltering J.Crew Names Jan Singer CEO
    Singer's previous gigs were a not-very-successful two years as CEO of Victoria's Secret, 22 months as Spanx CEO, and 10 years leading Nike footwear, apparel teams.
  • Feds, NY AG Hit 'Pharma Bro' Martin Shkreli With New Charges
    Martin Shkreli, now spending his time in federal prison for securities fraud, is facing new charges of price fixing for the drug Daraprim.
  • Clayton Christensen, Who Disrupted Conventional Thinking, Dies At 67
    Christensen pioneered the idea of disruptive innovation: "new, cheaper and seemingly inferior ideas in business and technology have potential to create entirely new markets."
  • Day Of Reckoning For Insys, Wells Fargo, Martinair Executives
    Insys Therapeutics executives received prison terms for orchestrating a criminal conspiracy to bribe doctors to prescribe Subsys, a highly addictive oral fentanyl spray.
« Previous EntriesNext Entries »